Split History
ETFs Holding ASMB »    ASMB Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Assembly Biosciences is a clinical-stage biotechnology company. Co. is developing two programs: a class of oral therapeutic candidates for the treatment of chronic hepatitis B virus (HBV) infection and a class of oral live microbial biotherapeutic candidates, which are designed to treat disorders related with the microbiome. Co.'s lead HBV core inhibitor product candidate is ABI-H0731. ABI-H2158, its second product candidate in the HBV Cure program. ABI-H3733 is Co.'s third product candidate in the HBV Cure program. Co. has started a clinical study of ABI-M201 to evaluate the safety and its effects on disease activity measures in patients with mildly to moderately active ulcerative colitis. According to our ASMB split history records, Assembly Biosciences has had 1 split.
ASMB split history picture
Assembly Biosciences (ASMB) has 1 split in our ASMB split history database. The split for ASMB took place on July 14, 2014. This was a 1 for 5 reverse split, meaning for each 5 shares of ASMB owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 200 share position following the split.

When a company such as Assembly Biosciences conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the ASMB split history from start to finish, an original position size of 1000 shares would have turned into 200 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Assembly Biosciences shares, starting with a $10,000 purchase of ASMB, presented on a split-history-adjusted basis factoring in the complete ASMB split history. ASMB split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 06/24/2011
End date: 06/23/2021
Start price/share: $76.25
End price/share: $3.98
Dividends collected/share: $0.00
Total return: -94.78%
Average Annual Total Return: -25.56%
Starting investment: $10,000.00
Ending investment: $521.63
Years: 10.01
Date Ratio
07/14/20141 for 5
ASMB is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

ASTM Split History
ASTX Split History
ATEC Split History
ATNM Split History
ATOS Split History
ATRC Split History
ATRI Split History
AVEO Split History
AVGR Split History
AVXL Split History

Also explore: ASMB shares outstanding history

Trisura Group Ltd. (TSU.CA)
BetaPro NASDAQ-100 2x Daily Bull ETF (HQU)
BetaPro S&P 500 2x Daily Bull ETF (HSU)
BetaPro S&P/TSX Capped Energy 2x Daily Bull ETF (HEU)
BetaPro S&P/TSX Capped Financials 2x Daily Bull ETF (HFU)
BetaPro S&P/TSX 60 2x Daily Bull ETF (HXU)
BetaPro Crude Oil Leveraged Daily Bull ETF (HOU)
Horizons Big Data & Hardware Index ETF (HBGD.U)
Horizons Big Data & Hardware Index ETF (HBGD)
Horizons NASDAQ-100 Index ETF (HXQ.U)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

ASMB Insider Buying

ASMB Split History | www.SplitHistory.com | Copyright © 2013 - 2021, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.